Results 171 to 180 of about 84,383 (263)
KRAS driven expression signature has prognostic power superior to mutation status in non-small cell lung cancer [PDF]
Á. Nagy+3 more
openalex +1 more source
This article explores the development of rhodamine TEMPO conjugates via the Ugi‐multicomponent reaction to detect reactive oxygen species (ROS) in living cells. The sensors are highly selective for mitochondria in both cancer and normal cell lines, with fluorescence quenching and EPR spectroscopy offering precise ROS detection.
Haider N. Sultani+6 more
wiley +1 more source
Editorial: Mutational signatures and immune response in cancer. [PDF]
Georgakopoulos-Soares I, Zaravinos A.
europepmc +1 more source
Combining Mutational Signatures, Clonal Fitness, and Drug Affinity to Define Drug-Specific Resistance Mutations in Cancer [PDF]
Teresa Kaserer, Julian Blagg
openalex +1 more source
Machine Learning‐Driven Multi‐Objective Optimization of Microchannel Reactors for CO₂ Conversion
This study introduces a novel method that combines CFD, RSM, and ML to improve a microreactor's performance utilizing the Sabatier reaction. A range of ML models is assessed, and the best one is selected to predict optimal reactor conditions. ML shows the ability to predict performance in just milliseconds, leading to a decrease in computational time ...
Sandeep Kumar+2 more
wiley +1 more source
The therapeutic significance of mutational signatures from DNA repair deficiency in cancer [PDF]
Jennifer Ma+4 more
openalex +1 more source
This study analyses the electronic structure of five‐electron spherical quantum dots with penetrable confinement potential. Spatial confinement and the influence of potential barrier height give rise to the unique properties of quantum dots. These effects lead to profound changes in their energy spectra and optical properties which play a key role in ...
Yusuf Yakar, Bekir Çakır, Ayhan Özmen
wiley +1 more source
The Repertoire of Mutational Signatures in Human Cancer [PDF]
Ludmil B. Alexandrov+20 more
openalex +1 more source
This study provides proof‐of‐concept evidence showing that through direct killing, antigen presentation, and competitively binding to BTN3A1, Vγ9Vδ2 T cells amplified from cervical cancer (CC) patients can synergize with αβ T cells to exert anti‐CC function both in vitro and in vivo.
Min Wu+21 more
wiley +1 more source